STRM.BIO (pronounced “storm bio”) is a VC-backed biotech startup building a new kind of gene therapy delivery platform based on naturally occurring extracellular vesicles (EVs). We're leveraging the unique biology of EVs to unlock targeted, scalable, and low-immunogenicity genetic medicines that target the bone marrow.
We’re a small, fast-moving team based at The Engine in Cambridge, MA. We believe in simplicity, integrity, and keeping people at the center of everything we do. We’re here to do great science and build a company we’re proud of.
THE OPPORTUNITY
We’re looking for Research Associates to help grow our research engine. You’ll work shoulder-to-shoulder with the Director of Research and a team of Scientists to support key programs and facilitate external collaborations. This is a hands-on, highly cross-functional role ideal for someone who’s ready to dive in and execute in equal measure. This is a full-time, on-site role.
WHAT YOU’LL DO (Key Responsibilities)
- Support the Research Team in efforts across multiple collaborative research programs
- Contribute to R&D efforts to meet project milestones, maintaining the standards of scientific rigor and adhering to ethical standards
- Maintain standards consistent with company culture and values
- Work closely with team members to maintain project development, implementation and troubleshooting of experiments
- Generate, analyze, and share experimental results and ensure that all protocols, reagents, data, and analyses are documented following data integrity principles and prepared and made available in a timely manner
- Attend team meetings to discuss results, future plans and experiments, with a keenness to help achieve company milestones
- Maintain comprehensive and up-to-date knowledge of molecular and cellular biology techniques
- Perform other duties as assigned, including all those associated with facilitating the smooth operation of a wet lab environment
- Maintain accurate records in electronic lab notebooks (ELNs) and contribute to documentation for internal reports and regulatory filings
- Attend regular EHS meetings and maintain accurate biologic and chemical records
- B.S. or M.S. in biology, immunology, bioengineering, or related field
- Some prior industry experience is strongly preferred
- Academic or industry experience working with T cells in a research setting
- Familiarity with gene-editing technologies (e.g., CRISPR, TALEN, ZFNs) and delivery platforms (e.g., viral vectors, LNPs, exosomes)
- Previous involvement in in vivo studies or willingness to learn animal handling and vivarium protocols
- Strong organizational and communication skills, with comfort operating in interdisciplinary project teams
- Prior experience with CRO collaboration or CMC workflows is a bonus
- 100% on-site in Cambridge, MA
- Full time with competitive compensation
- The salary range for this position is $70,000 to $90,000 USD annually. This salary range is an estimate, and the actual salary may vary based on various factors, including, without limitation, individual education, experience, tenure, skills, and abilities, as well as internal equity and alignment with market data, including potential adjustments for geographic location.
- The salary range for this position is $70,000 to $90,000 USD annually. This salary range is an estimate, and the actual salary may vary based on various factors, including, without limitation, individual education, experience, tenure, skills, and abilities, as well as internal equity and alignment with market data, including potential adjustments for geographic location.
Top Skills
What We Do
Based in Boston, MA, STRM.BIO (“storm bio”) is a pre-clinical, VC-backed biotechnology company that aims to fulfill the promise of gene therapy by leveraging extracellular vesicles (EVs) to deliver treatment directly to the patient (in vivo). Unlike viruses, EVs are natural carriers of nucleic acids and proteins with innate targeting capabilities, amenability to large scale/commercial manufacture, and low immunogenicity – which make them excellent cell messengers for gene therapies. Our proprietary EV platform is establishing a whole new class of therapeutics, yielding new therapies and making existing ones more effective. At STRM.BIO, we believe that our work has the potential to democratize gene therapy and bring hope for patients fighting rare diseases worldwide. We are currently recruiting team members who can help us make our vision a life-saving reality.
